Skip to main content
$22.17 $0.66 (3.1%)

04:00 PM EDT on 06/18/21

Cel-sci Corp (NYSEMKT:CVM)

CAPS Rating: 1 out of 5

The Company engages in the research and development of drugs and vaccines. Its most advanced product, Multikine, manufactured using the Company's proprietary cell culture technologies, is being developed for the treatment of cancer.

Current Price $22.17 Mkt Cap $914.8M
Open $21.05 P/E Ratio 0.00
Prev. Close $24.72 Div. (Yield) $0.00 (0.0%)
Daily Range $21.01 - $22.62 Volume 1,364,489
52-Wk Range $10.76 - $40.91 Avg. Daily Vol. 983,481

Caps

How do you think NYSEMKT:CVM will perform against the market?

Add Stock to CAPS Watchlist

All Players

97 Outperform
37 Underperform
 

All-Star Players

8 Outperform
13 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:CVM Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

ejad1 (< 20)
Submitted January 16, 2014

CVM is expecting to conclude its phase III of Multikrine end 2014 or early 2015

zzlangerhans (97.88)
Submitted June 05, 2016

Has it really been over a year since I looked at Cel-Sci? I knew my life was missing something. Catching up was very entertaining. Things are as scuzzy and futile as ever over at Cel-Sci.Last February I pointed out that the company's claim of being… More

NYSEMKT:CVM VS S&P 500 (SPY)

Fools bullish on NYSEMKT:CVM are also bullish on:

Fools bearish on NYSEMKT:CVM are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CVM.

Recs

0
Member Avatar usubanas2 (99.12) Submitted: 3/30/2021 11:44:13 AM : Underperform Start Price: $15.32 NYSE MKT:CVM Score: -39.58

Ph3 trial will fail

Recs

0
Member Avatar naughtyguy (30.67) Submitted: 2/5/2021 8:20:08 PM : Outperform Start Price: $18.23 NYSE MKT:CVM Score: +12.56

cancer stock ... just finished phase 3 fda will consider approval or disapproval soon.

Recs

0
Member Avatar rosepicker (< 20) Submitted: 4/23/2020 12:29:15 AM : Outperform Start Price: $10.83 NYSE MKT:CVM Score: +87.03

This company is about to have the FDA approve their cure for cancer.

Leaderboard

Find the members with the highest scoring picks in CVM.

Score Leader

jeepdrew222

jeepdrew222 (80.72) Score: +1,088.74

The Score Leader is the player with the highest score across all their picks in CVM.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
jeepdrew222 80.72 8/28/2018 Outperform 5Y $1.80 +1,131.67% +42.93% +1,088.74 0 Comment
caelin389 59.81 5/17/2018 Outperform 5Y $2.82 +686.17% +52.36% +633.81 0 Comment
GabrielSevrs 25.10 11/5/2018 Outperform 3W $3.40 +552.06% +52.30% +499.76 0 Comment
retirebefore50 < 20 9/27/2018 Outperform 5Y $4.11 +439.42% +42.60% +396.81 0 Comment
dexxyru < 20 9/24/2009 Underperform 5Y $397.50 -94.42% +294.83% +389.25 0 Comment
DarthMaul09 28.69 10/16/2009 Underperform 5Y $387.50 -94.28% +281.36% +375.64 4 Comments
pennycruncher < 20 10/19/2009 Underperform 5Y $380.00 -94.17% +280.42% +374.58 0 Comment
bermuda999 21.84 8/16/2010 Underperform 1Y $125.25 -82.30% +285.72% +368.02 0 Comment
arboretum 29.29 6/14/2010 Underperform 5Y $125.00 -82.26% +275.43% +357.69 0 Comment
qasamm < 20 1/3/2011 Underperform 3M $209.88 -89.44% +227.46% +316.89 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CVM.